Table 4 Mega A rounds of 2019

From: Europe’s biotech renaissance

CompanyAmount ($ millions)DateRegionBusiness
FerGene57025 NovemberSaint-Prex, SwitzerlandCancer gene therapy
Nuvation Bio27528 OctoberNew YorkOncology
Anthos Therapeutics25027 FebruaryCambridge, MassachusettsTargeted cardiovascular therapy
Century Therapeutics2501 JulyPhiladelphia, PennsylvaniaStem cells and oncology
Arvelle Therapeutics207.51 JanuaryZug, SwitzerlandCentral nervous system
Maze Therapeutics19127 FebruarySouth San Francisco, CaliforniaFunctional genomics
ElevateBio15013 MayCambridge, MassachusettsCell and gene therapy
Passage Bio115.514 FebruaryPhiladelphia, PennsylvaniaNeurology, cell and gene therapy
Thrive Earlier Detection11030 MayCambridge, MassachusettsDiagnostic
Kronos Bio10518 JulySan Mateo, CaliforniaCancer
Talaris Therapeutics10018 AprilBoston, MassachusettsCell and gene therapy, transplantation
  1. Source: BCIQ BioCentury Online Intelligence